We further compared the risk score between patients with different clinical characteristics and found that the LMG signature was associated with age, tumor grade, IDH mutation, radiotherapy, and the O-methylguanine-DNA-methyltransferase (MGMT) status (Figure 4A). This evidence concerns the gene MGMT and neoplasm.